Target intelligence / Profile preview

RNA, U6 small nuclear 1226, pseudogene (RNU6-1226P)

Target
RNU6-1226P
Molecular classification
Other, Pseudogene, small nuclear RNA (snRNA) family
01

Overview

RNU6-1226P is a pseudogene member of the U6 small nuclear RNA family, annotated in the HGNC database (HGNC:48189), with NCBI Gene ID: 106480102 and Ensembl ID: ENSG00000207044[3][5][7][8]. Pseudogenes are non-functional genomic sequences derived from formerly functional genes, and RNU6-1226P does not encode a functional RNA or protein product. Unlike canonical U6 snRNA members—which play a role in mRNA splicing within the spliceosome[2]—pseudogenes such as RNU6-1226P have no confirmed biological function, clinical relevance, or role as therapeutic targets. There are no known disease associations, interacting drugs, or biomarker utility[8]. Key points: - Not a protein or receptor target: This gene encodes a non-coding RNA; as a pseudogene, it is not functionally involved in canonical biological processes or relevant as a drug target[8]. - No known disease or drug associations: There is no evidence linking RNU6-1226P to diseases, nor is it a biomarker or a safety concern[8]. - Proper annotation: The entry matches the officially recognized nomenclature, with no obvious errors or misinformation[7][8]. - No direct relevance to drug development or clinical application: If searching for a true therapeutic target, consider genuine U6 snRNA genes (such as RNU6-1) involved in the spliceosome, not this pseudogene variant[6].

Other names
RNU6-1226PRNA, U6 Small Nuclear 1226, Pseudogene

Beyond the preview

Go deeper on RNA, U6 small nuclear 1226, pseudogene (RNU6-1226P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 1226, pseudogene (RNU6-1226P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call